EINDHOVEN, Netherlands - ONWARD Medical N.V. (Euronext:ONWD, US ADR: ONWRY), a medical technology company with a market capitalization of $52.46 million, announced Monday that the U.S. Food and Drug ...

New technology is helping people with paralysis move again, and it doesn't involve surgery, needles or drugs. It's a first-of-its-kind non-invasive spinal cord stimulation therapy, and it's now ...

Detailed results from clinical feasibility studies show immediate improvement in blood pressure stability and durable reduction of hypotensive symptoms, resulting in improved quality of life Most ...

Christopher Maher holds a research fellowship funded by the National Health and Medical Research Council. Caitlin Jones does not work for, consult, own shares in or receive funding from any company or ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial. It's a ...

A stem cell treatment helped improve the motor function of two out of four patients with a spinal cord injury in the first clinical study of its kind, Japanese scientists said. There is currently no ...

ONWARD's ARC-EX System uses spinal cord stimulation to boost strength and mobility, offering new hope for Veterans and those with spinal cord injuries. We’re excited to see the ARC-EX System receive ...

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

How did the bodies of animals, including ours, become such fine-tuned movement machines? This paper cuts directly into critical debates about how the ancient spinal cord and the relatively new human ...

How did the bodies of animals, including ours, become such fine-tuned movement machines? How vertebrates coordinate the eternal tug-o-war between involuntary reflexes and seamless voluntary movements ...